ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Operating Cash Flow

Cash generated by the company's core business operations during the period.

No reported Operating Cash Flow figures are available to summarize.

Operating Cash Flow history

Currency unavailable · from the cash flow

No Operating Cash Flow data reported for this period type.

Operating Cash Flow vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Operating Cash Flow for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WVEWave Life Sciences Ltd.LTM Mar 2026$182.35M USD+1.0%+13.6%254.0%
PRMEPrime Medicine, Inc.LTM Mar 2026$156.42M USD+50.4%+7.2%3877.5%
STOKStoke Therapeutics, Inc.LTM Mar 2026$146.82M USD-311.1%—457.7%
SLNSilence Therapeutics plcLTM Mar 2026$65.57M USD—+3.0%7115.1%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$58.57M USD-34.4%—129.2%
PRQRProQR Therapeutics N.V.LTM Mar 2026€48.04M EUR+29.6%-9.5%357.4%
RNAAtrium Therapeutics, Inc.FY2025$41.13M USD——220.9%
BNTCBenitec Biopharma Inc.LTM Mar 2026$20.57M USD+10.2%+14.1%—
MGTXMeiraGTx Holdings plcLTM Mar 2026$8.28M USD+107.9%-14.1%10.4%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+10.2%+5.1%305.7%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.